Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors;Análise do uso da PCR em tempo real para HTLV-1 e 2 como teste confirmatório na triagem de doadores de sangue

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 2, 2010, Pages 111-115

  Andrade, Rafaela Gomes ^a,b   Ribeiro, Maísa Aparecida ^a,b   Namen Lopes, Maria Sueli Silva ^a,b   Silva, Sônia Mara Nunes ^a   Basques, Fernando Valadares ^a   Ribas, João Gabriel ^a   Carneiro Proietti, Anna Bárbara de Freitas ^a,b   Martins, Marina Lobato ^a,b  

^a Secretary of Health of the Minas Gerais State   (Brazil)

^b Interdisciplinary HTLV Research Group (GIPH)   (Brazil)

Author keywords

Blood donors; HTLV; Real time PCR; Western blot

Indexed keywords

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; COST; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INTERMETHOD COMPARISON; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS CARRIER; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS TYPING; WESTERN BLOTTING;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 77954168297     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822010000200001     Document Type: Article

References (34)

1. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24:6058-6068.
2. Hall WW, Kubo T, Ijichi S, Takahashi H, Zhu SW. Human T-cell leukemia/ lymphoma virus, type II (HTLV-II): emergence of an important newly recognized pathogen. Sem Virol 1994; 5:165-178.
3. Maloney E, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw GM, et al. Endemic human T cell lymphotropic virus type II infection among isolate Brazilian amerindians. J Infect Dis 1992; 166:100-107.
4. Mahieux R, Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol 2009; 57:161-166.
5. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington Jr W, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009; 27:453-459.
6. De Castro-Costa CM, Araújo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, et al. Proposal for diagnostic criteria of tropical spastic paraparesis/ HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 2006; 22:931-935.
7. Carneiro-Proietti AB, Ribas JG, Catalan-Soares BC, Martins ML, Brito-Melo GE, Martins-Filho AO, et al. Infecção e doença pelo vírus linfotrópicos humanos de células T (HTLV-I/II) no Brasil. Rev Soc Bras Med Trop 2002; 35:499-508.
8. Farre L, de Oliveira MF, Primo J, Vandamme AM, Van Weyenbergh J, Bittencourt AL. Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/ lymphoma. Clin Infect Dis 2008; 46:440-442.
9. Nobre V, Guedes AC, Proietti FA, Martins ML, Nassif G, Serufo JC, et al. Increased prevalence of human T cell lymphotropic virus type 1 in patients attending a Brazilian dermatology clinic. Intervirology 2007; 50:316-318.
10. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004; 6:144-154.
11. Take H, Umemoto M, Kusuhara K, Kuraya K. Trasmission routes of HTLV-I: an analysis of 66 families. Jpn J Cancer Res 1993; 84:1265-1267.
12. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46:245-253.
13. Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, Wharfe G, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 1999; 180:1487-1493.
14. Zarranz Imirizaldu JJ, Gomez Esteban JC, Rouco Axpe I, Perez Concha T, Velasco Juanes F, Allue Susaeta I, et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 2003; 74:1080-1084.
15. Catalan-Soares B, Carneiro-Proietti ABF, Proietti FA. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saúde Pública 2005; 21:926-931.
16. Alcantara LC, Shindo N, Van Dooren S, Salemi M, Costa MC, Kashima S, et al. Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs. AIDS Res Hum Retroviruses 2003; 19:519-523.
17. Berini CA, Eirin ME, Pando MA, Biglione MM. Human T-cell lymphotropic virus types I and II (HTLV-I and-II) infection among seroindeterminate cases in Argentina. J Med Virol 2007; 79:69-73.
18. Césaire R, Bera O, Maier H, Lezin A, Martial J, Ouka M, et al. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion 1999; 39:1145-1149.
19. Jacob F, Santos-Fortuna E, Azevedo RS, Caterino-de-Araújo A. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil. Rev Inst Med Trop São Paulo 2007; 49:361-364.
20. Mauclère P, Le Hesran JY, Mahieux R, Salla R, Mfoupouendoun J, Abada ET, et al. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa. J Infect Dis 1997; 176:505-509.
21. Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, et al. Significance of HTLV-1 proviral load quantification by real time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol 2003; 25:111-117.
22. Lee T-H, Chafets DM, Busch MP, Murphy EL. Quantitation of HTLV-I and II proviral load using real time quantitative PCR with SYBR Green chemistry. J Clin Virol 2004; 31:275-282.
23. Olindo S, Lézin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, et al. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 2005; 237:53-59.
24. Tamegão-Lopes BP, Rezende PR, Maradei-Pereira LMC, Lemos JAR. Carga proviral do HTLV-1 e HTLV-2: um método simples através da PCR quantitativa em tempo real. Rev Soc Bras Med Trop 2006; 39:548-552.
25. Andersson S, Thorstensson R, Ramirez KG, Krook A, von Sydow M, Dias F, et al. Comparative evaluation of 14 immunoassays for the detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa. Transfusion 1999; 39:845-851.
26. Thorstensson R, Albert J, Andersson S. Strategies for diagnosis of HTLV-I and HTLV-II. Transfusion 2002; 42:780-791.
27. Vrielink H, Reesink H, Habibuw M, Schuller M, van der Meer C, Lelie P. Comparison of four HTLV-I and HTLV-I + II ELISAs. Vox Sang 1999; 76:187-191.
28. Liu H, Shah M, Stramer SL, Chen W, Weibblen BJ, Murphy EL. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-I/II. Transfusion 1999; 39:1185-1193.
29. Morimoto HK, Morimoto AA, Reiche EM, Ueda LT, Matsuo T, Reiche FV, et al. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Rev Inst Med Trop São Paulo 2007; 49:225-230.
30. Poiesz BJ, Dube S, Choi D, Esteban E, Ferrer J, Leon-Ponte M, et al. Comparative perfomances of an HTLV-I/II EIA and other serologic and PCR assays on samples from persons at risk for HTLV-II infection. Transfusion 2000; 40:924-930.
31. Zehender G, De Maddalena C, Gianotto M, Cavalli B, Santambrogio S, Orso M, et al. High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type I-positive patients. AIDS Res Human Retrovirol 1997; 13:1141-1146.
32. Zaaijer HL, Cuypers HTM, Dudok De Wit C, Lelie PN. Results of 1-year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion 1994; 34:877-880.
33. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 2000; 40:443-449.
34. Medrano FJ, Soriano V, Calderón EJ, Rey C, Gutiérrez M, Bravo R, et al. Significance of indeterminate reactivity to human T-cell lymphotropic virus in Western blot analysis of individuals at risk. Eur J Clin Microbiol Infect Dis 1997; 16:249-252.